Oruka Therapeutics Inc (ORKA)
20.66
+0.16
(+0.78%)
USD |
NASDAQ |
Nov 22, 11:06
Oruka Therapeutics Shareholders Equity (Quarterly): 342.37M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 342.37M |
| June 30, 2024 | -28.98M |
| Date | Value |
|---|---|
| March 31, 2024 | -7.059M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-28.98M
Minimum
Jun 2024
342.37M
Maximum
Sep 2024
102.11M
Average
-7.059M
Median
Mar 2024
Shareholders Equity (Quarterly) Benchmarks
| LENZ Therapeutics Inc | 215.28M |
| TruBridge Inc | 172.65M |
| PetMed Express Inc | 96.43M |
| Streamline Health Solutions Inc | 15.90M |
| R1 RCM Inc | 2.811B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 414.09M |
| Total Liabilities (Quarterly) | 71.72M |